SB 640 revises Florida’s law governing the retail sale of ephedrine and related compounds, including ephedrine, pseudoephedrine, and phenylpropanolamine. The bill adds definitions for “administrator of the electronic recordkeeping system” and “covered entity,” and it narrows or clarifies which manufacturers are exempt from the statute while making certain manufacturers subject to electronic recordkeeping requirements.
The bill also updates the penalty structure for violations of the retail-sale restrictions. A first violation of the specified provisions would be a second-degree misdemeanor, a second violation a first-degree misdemeanor, and a third or subsequent violation a third-degree felony. The act is contingent on the passage of SB 642 or similar legislation in the same session, and would take effect July 1, 2025 if that condition is met.
Impact
If enacted, SB 640 would amend section 893.1495, Florida Statutes, by expanding statutory definitions, adjusting the scope of exemptions for manufacturers, and strengthening enforcement through explicit criminal penalties for repeated violations. It would affect manufacturers, retailers, and other entities involved in the sale or distribution of ephedrine-related products, particularly those required to use or comply with the state’s electronic recordkeeping system.
Sentiment
No committee transcripts or recorded votes were provided, so there is no direct evidence of support or opposition from legislative debate. Based on the bill text alone, the measure appears to be a regulatory and enforcement-focused proposal aimed at tightening controls on precursor chemicals used in the production of illegal drugs, which typically draws support from law enforcement and public safety interests.
Contention
The main points of potential contention are the expanded compliance obligations for manufacturers that qualify as covered entities, the use of an electronic recordkeeping system, and the escalation of criminal penalties for repeat violations. Businesses in the supply chain may view the bill as increasing administrative burden and exposure to criminal liability, while supporters are likely to argue that the changes improve oversight and help prevent diversion of precursor chemicals.